Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-24 @ 10:33 PM
NCT ID:
NCT01726335
Eligibility Criteria:
Inclusion Criteria:
* Have schizophrenia diagnosis by Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV)
* Be on treatment with oral antipsychotic of first or second generation, for a minimum time of 12 months
* Previous history of bad adhesion to oral antipsychotic treatment in the last 12 months
* Total Positive and Negative Syndrome Scale score less than or equal to 90, the conceptual disorganization, hallucinatory behavior, suspicion and not usual content of thought must be less than or equal to 4
* Be not pregnant as showed on negative pregnancy serum test
Exclusion Criteria:
* Contraindication or known hypersensitivity to risperidone
* Previous history of unsatisfactory response to risperidone
* Previous history of refractivity to the other second generation antipsychotics
* Use of antipsychotic of intramuscular deposit in the last 12 months
* Other mental disturbances of DSM-IV axis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT01726335
Study Brief:
Protocol Section:
NCT01726335